That was IR before split from Lannett. Below 7% as disclosed during cc, but expected to go higher. Much lower for Adderall ER and doesn’t sound like DEA is going to budge much. They expect to 1.5/2X what Lannett did, but that is a small fraction of Adderall ER market.